November 2020 FDA Recall Drug by The Harvard Drug Group
D-0114-2021 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by The Harvard Drug Group on November 18, 2020 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0114-2021

Reason for Recall
Failed Dissolution Specifications: Out of specification for dissolution.
Initiated
11-18-2020
Reported
12-09-2020
Quantity
841 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
The Harvard Drug Group
Aripiprazole Tablets, USP, 15 mg, 30 tablets per unit dose carton, Rx Only, Manufactured by: Apotex, Inc, Toronto, Ontario Canada M9L 1T9, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6512-04

Batch or Lot Expiration Information

Lot# Lots: T02520, T02637, exp 02/2021